Point72 Hong Kong’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-500
Closed -$5.07K 604
2023
Q4
$5.07K Buy
+500
New +$5.07K ﹤0.01% 566
2022
Q4
Sell
-20,224
Closed -$248K 406
2022
Q3
$248K Buy
+20,224
New +$248K 0.01% 511
2022
Q1
Sell
-2,935
Closed -$78K 1465
2021
Q4
$78K Buy
+2,935
New +$78K ﹤0.01% 697
2021
Q3
Sell
-7,023
Closed -$398K 1494
2021
Q2
$398K Buy
7,023
+5,036
+253% +$285K 0.01% 450
2021
Q1
$83K Buy
1,987
+875
+79% +$36.6K ﹤0.01% 677
2020
Q4
$78K Sell
1,112
-113
-9% -$7.93K ﹤0.01% 658
2020
Q3
$34K Buy
+1,225
New +$34K ﹤0.01% 751
2020
Q1
Sell
-125
Closed -$4K 1049
2019
Q4
$4K Buy
+125
New +$4K ﹤0.01% 1042
2018
Q4
Sell
-1,461
Closed -$46K 965
2018
Q3
$46K Buy
+1,461
New +$46K 0.02% 474
2018
Q2
Sell
-1,232
Closed -$41K 957
2018
Q1
$41K Buy
+1,232
New +$41K 0.02% 502